CommentaryPlatelet alloantigens: cardiovascular as well as immunological risk factors?
References (15)
Nomenclature of human platelet alloantigens: A problem with the HPA system?
Blood
(1994)- et al.
Clues to the death of an Olympic champion
Lancet
(1996) - et al.
Platelet glycoprotein IIIa P1A polymorphism in young men with myocardial infarction
Lancet
(1996) - et al.
Platelet glycoprotein IIIa gene polymorphism and myocardial infarction
Lancet
(1996) - et al.
Platelet glycoprotein IIIa P1A polymorphism and Japanese diabetic patients with coronary heart disease
Lancet
(1996) - et al.
Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia
J Clin Invest
(1996) - et al.
Alloimmune Thrombocytopenias
There are more references available in the full text version of this article.
Cited by (29)
Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation
2002, Transplant ImmunologyGenetic determinants of arterial thrombosis
1999, Bailliere's Best Practice and Research in Clinical HaematologyInsights into the pathophysiology of unstable coronary artery disease
1997, American Journal of Cardiology
Copyright © 1997 Elsevier Ltd. All rights reserved.